Portage Biotech, Inc.
About Portage Biotech, Inc.
Products & Services
Specialties
Funding History
Debug: View Raw Funding Data
| # | Type | Amount Fields | Date Fields | Investors |
|---|---|---|---|---|
| 1 |
RT: Private Placement T: - FT: Private Placement |
A: 2150000 MR: - FA: $2.15 million FAN: 2150000 |
D: 2025-01-30 FD: 2025-01-30 |
1 investors |
| 2 |
RT: Non-dilutive T: - FT: Non-dilutive |
A: 2800000 MR: - FA: $2.8M FAN: 2800000 |
D: 2024-03-26 FD: 2024-03-26 |
- |
| 3 |
RT: Registered Direct Offering T: - FT: Registered Direct Offering |
A: 6000000 MR: - FA: $6.0 million FAN: 6000000 |
D: 2023-09-29 FD: 2023-09-29 |
1 investors |
Growth Metrics
Team & Leadership
Robert Kramer
Chief Scientific Officer
Andrea Park
Chief Financial Officer
Adam Melero
Controller
Alexander Pickett
CEO and Director
Gregory Bailey
Lead Director
Steven Mintz
Director
Recent News
Portage Biotech, Inc. Announces New Product Launch
2 days agoCompany unveils innovative solution to transform the industry, expanding market reach and capabilities...
Read more →Leadership Team Expands with Industry Veteran
1 week agoNew executive brings 20+ years of experience to accelerate growth and strategic initiatives...
Read more →Company Recognized as Industry Leader
2 weeks agoReceives prestigious award for innovation and customer satisfaction in competitive market...
Read more →Key Competitors
Competitor Alpha
Series B · $50M raised
Competitor Beta
Series C · $120M raised
Competitor Gamma
Series A · $25M raised
Competitor Delta
Seed · $10M raised
Company Details
- Website
- portagebiotech.com
- Industries
- Biotechnology / Immuno-Oncology
- Company Size
- ~135 employees (est.)
- Locations
-
DOVER, Del.
Dover, Del.
Dover, Delaware
Technology Stack
Discover the backend, frontend, and infrastructure technologies powering this company's products.
Upgrade to Pro